The ELECTRA trial found that the combination of elacestrant and abemaciclib was well-tolerated and showed promising clinical ...
Superior efficacy at 12 weeks was seen with the frontline combination of abemaciclib and endocrine therapy vs standard ...
4d
MEDSIR, a leading company dedicated to promoting independent clinical research in oncology internationally and part of ...
Abemaciclib is under clinical development by Eli Lilly and Co and currently in Phase I for Metastatic Renal Cell Carcinoma.
Singaporeans are used to hearing about the aspirational 5Cs: cash, condo, car, credit card, and club membership. But there’s ...
The research published in the journal The Lancet Oncology has revealed that complete axillary lymph node dissection (cALND) to determine the indication for abemaciclib (to avoid cancer recurrence over ...
Atossa Therapeutics and Quantum Leap Healthcare Collaborative have dosed the first patient in the I-SPY 2 Trial of the former’s (Z)-endoxifen, along with abemaciclib (VERZENIO), for breast ...
Credit: Ground Picture / Shutterstock. Atossa Therapeutics and Quantum Leap Healthcare Collaborative have dosed the first patient in the I-SPY 2 Trial of the former’s (Z)-endoxifen, along with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback